Oracle's $638 Billion Backlog Meets a $23.7 Billion Cash Burn: The High-Stakes Math of an AI Bet

Oracle's AI bet drains cash flow, but backlog hits $638B. Analysts cut targets yet keep buy ratings. Q1 earnings due Sept 10.

There is a number that captures Oracle's predicament better than any earnings call: $23.7 billion. That is how much negative free cash flow the software giant generated last fiscal year—a figure that would look more at home in a venture-backed startup's pitch deck than in the books of a company once synonymous with steady margins and predictable balance sheets.

Yet the same company is sitting on an order backlog of $638 billion, up 363 percent year over year. Those two figures, in tension with one another, define Oracle's autumn of 2026: a business that has bet everything on artificial intelligence, and a market trying to decide whether the wager will pay off before the financing costs consume it.

The stock, trading around €126, sits roughly 57 percent below its 52-week high of €294.85 hit on September 10, 2025, and is down 24 percent year to date. On Tuesday, shares fell 5.4 percent amid a global bond market selloff that pushed long-term government yields to multi-year highs—a direct hit for a company that has borrowed $43 billion over the past fiscal year and plans roughly $40 billion more in combined debt and equity financing this year.

Wall Street's Curious Consensus: Lower Targets, Steady Buy Ratings

The analyst community has responded to Oracle's balancing act with something that looks like cautious conviction. Jefferies trimmed its price target on September 2 from $320 to $290 while maintaining a "Buy" rating, citing a seasonally soft first quarter and lingering concerns about financing and execution of the AI data center strategy—issues the firm expects to persist for several quarters. A day earlier, TD Cowen cut its target to $240, also keeping a buy recommendation, pointing to the free cash flow drain from the AI expansion.

Both firms are looking at the same date on the calendar: October 28, when Oracle hosts its investor day, widely viewed as the next major catalyst.

This pattern—descending price targets alongside reaffirmed buy ratings—is familiar territory for capital-intensive growth stories. Analysts believe in the long-term narrative but question the timing and capital discipline. It is the perennial infrastructure-boom question: who funds the buildout before the revenue arrives?

The growth numbers fueling that belief are hard to dismiss. Cloud revenue rose 39 percent last fiscal year to $34 billion, with the OCI infrastructure unit surging 77 percent to $18.1 billion. For the upcoming quarter, analysts expect revenue growth of 28 percent on a constant-currency basis and earnings per share growth of 18.5 percent. Barchart pegs long-term CAGR expectations even higher, at 31 percent for revenue and 28 percent for earnings.

A Partner in HPE, A Watchful Eye in Brussels

On the operational front, there are signs Oracle is seeking to share the load. HPE announced on September 2 an expanded collaboration to scale Oracle's global AI infrastructure, with HPE Juniper Networking slated for deployment across Oracle's data centers, backed by financing components and network support. Notably, HPE issued warrants on its own shares to Oracle as part of the deal—a measure of how deeply partners are now financially intertwined with Oracle's expansion plans.

The regulatory environment is growing less hospitable. On September 1, the European Commission began soliciting third-party information on Oracle's licensing practices, monitoring potential anticompetitive conduct in the cloud sector. The Commission stresses no formal investigation is underway against any company, but the scrutiny itself signals Oracle's evolution from database vendor to structural player in cloud—and the political attention that comes with it.

Stateside, CEO Larry Ellison faces a different kind of hearing. The House Veterans' Affairs Committee is examining the electronic health records system for veterans, whose budget has ballooned from $10 billion in 2018 to over $27 billion, with estimated lifetime costs reaching $50 billion. Representative Budzinski has voted to subpoena Ellison. Not a stock-moving event for most investors, but another front in a widening arena of political oversight.

The Layoff Calculus and a Recovering Share Price

Oracle is also trimming its workforce—7,000 to 10,000 positions may be affected, with potential announcement dates of September 15 or 30. Headcount has already fallen from 162,000 to 141,000. The cuts fit the profile of a company trying to fund growth while managing costs across multiple fronts simultaneously.

Despite the pressures, the stock showed signs of life recently, climbing 3.2 percent in a single session to €125.82, roughly 3.7 percent above its 50-day moving average though still 14 percent below its 200-day average. That suggests stabilization at lower levels rather than a trend reversal—modest encouragement, nothing more.

One Bernstein analyst sees potential for the stock to double, arguing that the end of aggressive capital-raising rounds may be in sight. The HPE partnership, which shifts some burden toward collaboration rather than pure self-financing, lends some credence to that view.

The Risks That Won't Go Away

The bear case remains substantial. Net debt stands at 4.5 times EBITDA, a leverage level exceeding that of hyperscalers like Amazon, Alphabet, and Meta, which fund their AI investments largely from operating cash flow. Customer concentration is another vulnerability, particularly the dependence on the OpenAI relationship.

The stock trades near the midpoint of its 52-week range—€100.76 at the low end, €294.85 at the high—a wide band that reflects just how much uncertainty surrounds the company's trajectory.

Oracle's Q1 earnings for fiscal year 2027, scheduled for September 10, will offer the next test of whether the $638 billion backlog can translate into actual cash generation. The October 28 investor day will force management to explain why the capital being consumed by this buildout will eventually burn bright enough to justify the cost. Between now and then, the market will keep doing what it does best with high-risk growth stories: weighing the promise of the backlog against the math of the balance sheet.